EXPORT CITATION

Chapter-14 Current Management of Abnormal Cervical Smears in Pregnant Women

BOOK TITLE: Cytology and Colposcopy in Gynecological Practice

Author
1. Kesic Vesna
ISBN
9788184485844
DOI
10.5005/jp/books/10194_14
Edition
1/e
Publishing Year
2009
Pages
12
Author Affiliations
1. Institute of Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade, Serbia; Medical School, University of Belgrade, Institute of Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade, Serbia, Medical School, University of Belgrade
Chapter keywords

Abstract

There has been an increased frequency of cervical intraepithelial neoplasia (CIN) in pregnancy. The incidence of invasive cervical cancer in pregnancy is between 1.6 to 10.6 per 10,000 pregnancies. The incidence of abnormal cytologic findings during pregnancy is 0.72–1.67%. If the experienced colposcopist estimates that the lesion is intraepithelial, biopsy can be omitted, because the finding of preinvasive disease does not influence the decision on therapy during pregnancy. Biopsy is thus limited to highly significant lesion, where invasion cannot be otherwise excluded. Endocervical curettage (ECC) should be avoided during pregnancy. The natural history of CIN in pregnancy explains why no treatment of these lesions in pregnancy is necessary. The rate of progression to invasive cervical cancer is longer than the gestation. The treatment of Invasive Cervical Cancer should be planned in collaboration with an Oncologist. It is possible currently to give chemotherapy to delay delivery by a few weeks to get a viable foetus. Prognosis of pregnant patients with cervical cancer is the same as that of non pregnant patients.

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved